Kylie Johnston1, Karen Grimmer-Somers. 1. Kylie Johnston, PhD, BAppSc (Physiotherapy): Research Officer, International Centre for Allied Health Evidence, Sansom Institute of Health Research, University of South Australia, Adelaide, Australia.
Abstract
PURPOSE: This report highlights the current international gap between the availability of high-quality evidence for pulmonary rehabilitation (PR) and its low level of implementation. Key barriers are outlined, and potentially effective strategies to improve implementation are presented. SUMMARY OF KEY POINTS: Although pulmonary rehabilitation (PR) is recommended by international guidelines as part of the management of patients with chronic obstructive pulmonary disease (COPD), participation in PR remains low. Physician referral to PR ranges from 3% to 16% of suitable patients. Barriers to participation include limited availability of suitable programmes and interrelated issues of referral and access. Individual patient barriers, including factors relating to comorbidities and exacerbations, perceptions of benefit, and ease of access, contribute less overall to low participation rates. Chronic care programmes that incorporate self-management support have some benefit in patients with COPD. However, the demonstrated cost-effectiveness of PR is substantial, and efforts to improve its implementation are urgently indicated. CONCLUSION: To improve implementation, a holistic examination of the key issues influencing a patient's participation in PR is needed. Such an examination should consider the relative influences of environmental (e.g., health-service-related) factors, organizational factors (e.g., referral and intake procedures), and individual factors (e.g., patient barriers) for all participants. On the basis of these findings, policy, funding, service delivery, and other interventions to improve participation in PR can be developed and evaluated.
PURPOSE: This report highlights the current international gap between the availability of high-quality evidence for pulmonary rehabilitation (PR) and its low level of implementation. Key barriers are outlined, and potentially effective strategies to improve implementation are presented. SUMMARY OF KEY POINTS: Although pulmonary rehabilitation (PR) is recommended by international guidelines as part of the management of patients with chronic obstructive pulmonary disease (COPD), participation in PR remains low. Physician referral to PR ranges from 3% to 16% of suitable patients. Barriers to participation include limited availability of suitable programmes and interrelated issues of referral and access. Individual patient barriers, including factors relating to comorbidities and exacerbations, perceptions of benefit, and ease of access, contribute less overall to low participation rates. Chronic care programmes that incorporate self-management support have some benefit in patients with COPD. However, the demonstrated cost-effectiveness of PR is substantial, and efforts to improve its implementation are urgently indicated. CONCLUSION: To improve implementation, a holistic examination of the key issues influencing a patient's participation in PR is needed. Such an examination should consider the relative influences of environmental (e.g., health-service-related) factors, organizational factors (e.g., referral and intake procedures), and individual factors (e.g., patient barriers) for all participants. On the basis of these findings, policy, funding, service delivery, and other interventions to improve participation in PR can be developed and evaluated.
Authors: Andrew L Ries; Gerene S Bauldoff; Brian W Carlin; Richard Casaburi; Charles F Emery; Donald A Mahler; Barry Make; Carolyn L Rochester; Richard Zuwallack; Carla Herrerias Journal: Chest Date: 2007-05 Impact factor: 9.410
Authors: Maarten J Fischer; Margreet Scharloo; Jannie J Abbink; Alex J van 't Hul; Dirk van Ranst; Arjan Rudolphus; John Weinman; Klaus F Rabe; Adrian A Kaptein Journal: Respir Med Date: 2009-05-29 Impact factor: 3.415
Authors: Peter Lange; Finn Vejlø Rasmussen; Hanne Borgeskov; Jens Dollerup; Michael Skov Jensen; Klaus Roslind; Lill Moll Nielsen Journal: Prim Care Respir J Date: 2007-06
Authors: Kristen S Willard; Jamie B Sullivan; Byron M Thomashow; Catherine S Jones; Leonard Fromer; Barbara P Yawn; Alpesh Amin; Jean M Rommes; Rhonda Rotert Journal: Chronic Obstr Pulm Dis Date: 2016-10-06
Authors: Jordan M Ellis; Matthew C Whited; John Taylor Freeman; Ansley T Corson; John Paul Jameson; Stacey Greenway; David M Sager; Emily P Midgette; Eliza V Varju Journal: J Cardiopulm Rehabil Prev Date: 2018-09 Impact factor: 2.081
Authors: Kerry A Spitzer; Mihaela S Stefan; Aruna Priya; Quinn R Pack; Penelope S Pekow; Tara Lagu; Victor M Pinto-Plata; Richard L ZuWallack; Peter K Lindenauer Journal: Ann Am Thorac Soc Date: 2019-01
Authors: Jamile Ashmore; Rennie Russo; Jennifer Peoples; John Sloan; Bradford E Jackson; Sejong Bae; Karan P Singh; Steven N Blair; David Coultas Journal: Contemp Clin Trials Date: 2013-05-13 Impact factor: 2.226
Authors: Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Vincent S Fan; Emily R Locke; Paula Diehr; Anthony Wilsdon; Paul Enright; Sachin Yende; Mark Avdalovic; Graham Barr; Vishesh K Kapur; Rachel Thomas; Jerry A Krishnan; Gina Lovasi; Stephen Thielke Journal: Respiration Date: 2014-09-09 Impact factor: 3.580
Authors: Fanuel Meckson Bickton; Talumba Mankhokwe; Rebecca Nightingale; Cashon Fombe; Martha Mitengo; Langsfield Mwahimba; Wilfred Lipita; Laura Wilde; Ilaria Pina; Zainab K Yusuf; Zahira Ahmed; Martin Kamponda; Felix Limbani; Harriet Shannon; Enock Chisati; Andy Barton; Robert C Free; Michael Steiner; Jesse A Matheson; Adrian Manise; Sally J Singh; Jamie Rylance; Mark Orme Journal: BMJ Open Date: 2022-01-31 Impact factor: 2.692